Before the Bell
$
109.81
Change
+0.40 +0.37%
Volume
Volume 456
Jun 8, 2023, 5:11 a.m.
Real time quotes
Previous close
$ 109.41
$ 109.41
Change
-0.44 -0.40%
Day low
Day high
$109.40
$110.75

52 week low
52 week high
$100.08
$188.99

Market cap
$26.47B
Average volume
710,059
P/E ratio
4.28
Rev. per Employee
$2.79M
EPS
25.54
Dividend
N/A
Div yield
N/A
Ex dividend date
6/2/22
MarketWatch News on BNTX
-
Healthcare Stocks Are on Sale. These 2 Have Strong Growth Prospects.
- Nicholas Jasinski
-
BioNTech Revenue Falls but Beats Wall Street Estimates
- Angela Palumbo
-
BioNTech still sees COVID vaccine revenue of 5 bln euros in 2023
- Ciara Linnane
-
CORRECTED: BioNTech Q1 revenue 1.277 bln euros vs. 6.375 bln a year ago; FactSet consensus 1.061 bln
- Ciara Linnane
-
CORRECTED: BioNTech Q1 EPS 2.05 euros vs. 14.24 a year ago; FactSet consensus 29 cents
- Ciara Linnane
-
Moderna Posts Earnings Beat. There's Good News on Covid Vaccines Too.
- Josh Nathan-Kazis
-
Pfizer Stock Rises After Strong Sales Beat
- Josh Nathan-Kazis
-
BioNTech stock price target cut to $128 from $142 at J.P. Morgan
- Tomi Kilgore
-
BioNTech enters cancer drug partnership with DualityBio
- Ciara Linnane
-
BioNTech and DualityBio in partnership to develop therapies for solid tumors
- Ciara Linnane
-
Dow ends nearly 200 points higher as bank sector stress wanes
- William Watts
- Loading more headlines...
Other News on BNTX
-
Vaccine Fatigue Can Give Your Portfolio a Booster
- The Wall Street Journal Interactive Edition
-
Next Covid Boosters to Target New Strain
- The Wall Street Journal Interactive Edition
-
Pfizer’s Earnings Fall With Cooling Demand for Covid-19 Products
- The Wall Street Journal Interactive Edition
-
New Covid-19 Booster Shots: What to Know
- The Wall Street Journal Interactive Edition
-
Single Dose of Omicron-Targeting Vaccines to Become Main Covid-19 Shot in U.S.
- The Wall Street Journal Interactive Edition
-
Deutsche Bank, Amazon, GameStop: Stocks That Defined the Week
- The Wall Street Journal Interactive Edition
-
Moderna to Price Its Covid-19 Vaccine at $130 a Dose
- The Wall Street Journal Interactive Edition
-
China Approves First Homegrown mRNA Covid-19 Vaccine
- The Wall Street Journal Interactive Edition
-
Moderna CEO Defends Pricing Plans for Covid Shot
- The Wall Street Journal Interactive Edition
-
Moderna’s Earnings, Revenue Fall on Fewer Vaccine Sales
- The Wall Street Journal Interactive Edition
-
Novavax to Sell 1.5 Million More Covid Vaccines to U.S.
- The Wall Street Journal Interactive Edition
-
Pfizer Expects Drop in Revenue as Vaccine Demand Wanes
- The Wall Street Journal Interactive Edition
-
Johnson & Johnson Profit Falls 25%
- The Wall Street Journal Interactive Edition
-
A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them
- The Wall Street Journal Interactive Edition
-
J&J Slashes Production of Its Covid-19 Vaccine
- The Wall Street Journal Interactive Edition
-
China Lifts Ban on Australian Coal in Move to Mend Ties
- The Wall Street Journal Interactive Edition
-
Moderna Considers Price of $110-$130 for Covid-19 Vaccine
- The Wall Street Journal Interactive Edition
-
China to Allow Rapid Tests to Confirm Covid Cases
- The Wall Street Journal Interactive Edition
-
China’s mRNA Covid Vaccine Starts Test Production
- The Wall Street Journal Interactive Edition
-
Western Covid Medicine to China’s Rescue
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on BNTX
-
BioNTech Announces New ADS Repurchase Program
- GlobeNewswire
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com